- Sustainability
- DE&I
- Pandemic
- Finance
- Legal
- Technology
- Regulatory
- Global
- Pricing
- Strategy
- R&D/Clinical Trials
- Opinion
- Executive Roundtable
- Sales & Marketing
- Executive Profiles
- Leadership
- Market Access
- Patient Engagement
- Supply Chain
- Industry Trends
Now and Next: A COVID-19 Access and Patient Engagement Update
What market access looks like now and what’s next – a COVID-19 perspective from IQVIA. Live: Thursday, May 28, 2020, 2020 at 11am EDT On demand available after airing until May 28, 2021. Register free
Register free: http://www.pharmexec.com/pe_w/patient_engagement
EVENT OVERVIEW:
COVID-19 is front of mind for everybody. Many voices in the industry – including IQVIA – are releasing their own reports, updates, and estimates for what COVID-19 means for our businesses and clients. In this webinar, we will bring many of these dynamics together and lay the groundwork for pharma’s response to these uncertain times.
3 KEY TAKE-AWAYS:
- The impact to of shelter-in place protocols on pharmaceutical demand and the underlying drivers
- Shifting channel dynamics and the impact on manufacturer margin
- Geographic variations for impact and recovery
Speaker: Luke Greenwalt, Vice President, US Market Access Center of Excellence, IQVIA
Time and date: Thursday, May 28, 2020, 2020 at 11am EDT
On demand available after airing until May 28, 2021.
Sponsor: IQVIA
Register free: http://www.pharmexec.com/pe_w/patient_engagement
